Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound

Caterina Vicidomini, Federica Cioffi, Kerensa Broersen, Valentina Roviello, Claudia Riccardi, Daniela Montesarchio, Domenica Capasso, Sonia Di Gaetano, Domenica Musumeci (Corresponding Author), Giovanni N. Roviello (Corresponding Author)

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)

Abstract

Aim: Our goal is to evaluate benzodifuran-based scaffolds for biomedical applications. Methodology: We here explored the anticancer and anti-amyloid activities of a novel compound (BZ4) in comparison with other known benzodifuran analogs, previously studied in our group, and we have explored its ability to interact with different DNA model systems. Results: BZ4 shows antiproliferative activity on different cancer cells; does not affect noncancerous control cells and alters the aggregation properties of β-amyloid, as ascertained by circular dichroism, fluorescence spectroscopy and scanning electron microscopy analysis. An overall, qualitative picture on the mechanistic aspects related to the biological activities is discussed in light of the dynamic light scattering, UV, circular dichroism and fluorescence data, as well as of the metal ion-binding properties of BZ4.

Original languageEnglish
Pages (from-to)285-302
Number of pages18
JournalFuture Medicinal Chemistry
Volume11
Issue number4
DOIs
Publication statusPublished - 1 Feb 2019

Fingerprint

Circular Dichroism
Amyloid
Cell Aggregation
Fluorescence Spectrometry
Electron Scanning Microscopy
Fluorescence
Metals
Ions
DNA
Neoplasms
Lead
Dynamic Light Scattering

Keywords

  • anti-amyloid
  • anticancer
  • synthesis

Cite this

Vicidomini, Caterina ; Cioffi, Federica ; Broersen, Kerensa ; Roviello, Valentina ; Riccardi, Claudia ; Montesarchio, Daniela ; Capasso, Domenica ; Gaetano, Sonia Di ; Musumeci, Domenica ; Roviello, Giovanni N. / Benzodifurans for biomedical applications : BZ4, a selective anti-proliferative and anti-amyloid lead compound. In: Future Medicinal Chemistry. 2019 ; Vol. 11, No. 4. pp. 285-302.
@article{9998ed5cb5e641448b57b0751a20ddeb,
title = "Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound",
abstract = "Aim: Our goal is to evaluate benzodifuran-based scaffolds for biomedical applications. Methodology: We here explored the anticancer and anti-amyloid activities of a novel compound (BZ4) in comparison with other known benzodifuran analogs, previously studied in our group, and we have explored its ability to interact with different DNA model systems. Results: BZ4 shows antiproliferative activity on different cancer cells; does not affect noncancerous control cells and alters the aggregation properties of β-amyloid, as ascertained by circular dichroism, fluorescence spectroscopy and scanning electron microscopy analysis. An overall, qualitative picture on the mechanistic aspects related to the biological activities is discussed in light of the dynamic light scattering, UV, circular dichroism and fluorescence data, as well as of the metal ion-binding properties of BZ4.",
keywords = "anti-amyloid, anticancer, synthesis",
author = "Caterina Vicidomini and Federica Cioffi and Kerensa Broersen and Valentina Roviello and Claudia Riccardi and Daniela Montesarchio and Domenica Capasso and Gaetano, {Sonia Di} and Domenica Musumeci and Roviello, {Giovanni N.}",
year = "2019",
month = "2",
day = "1",
doi = "10.4155/fmc-2018-0473",
language = "English",
volume = "11",
pages = "285--302",
journal = "Future Medicinal Chemistry",
issn = "1756-8919",
publisher = "Future Science",
number = "4",

}

Vicidomini, C, Cioffi, F, Broersen, K, Roviello, V, Riccardi, C, Montesarchio, D, Capasso, D, Gaetano, SD, Musumeci, D & Roviello, GN 2019, 'Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound' Future Medicinal Chemistry, vol. 11, no. 4, pp. 285-302. https://doi.org/10.4155/fmc-2018-0473

Benzodifurans for biomedical applications : BZ4, a selective anti-proliferative and anti-amyloid lead compound. / Vicidomini, Caterina; Cioffi, Federica; Broersen, Kerensa; Roviello, Valentina; Riccardi, Claudia; Montesarchio, Daniela; Capasso, Domenica; Gaetano, Sonia Di; Musumeci, Domenica (Corresponding Author); Roviello, Giovanni N. (Corresponding Author).

In: Future Medicinal Chemistry, Vol. 11, No. 4, 01.02.2019, p. 285-302.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Benzodifurans for biomedical applications

T2 - BZ4, a selective anti-proliferative and anti-amyloid lead compound

AU - Vicidomini, Caterina

AU - Cioffi, Federica

AU - Broersen, Kerensa

AU - Roviello, Valentina

AU - Riccardi, Claudia

AU - Montesarchio, Daniela

AU - Capasso, Domenica

AU - Gaetano, Sonia Di

AU - Musumeci, Domenica

AU - Roviello, Giovanni N.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Aim: Our goal is to evaluate benzodifuran-based scaffolds for biomedical applications. Methodology: We here explored the anticancer and anti-amyloid activities of a novel compound (BZ4) in comparison with other known benzodifuran analogs, previously studied in our group, and we have explored its ability to interact with different DNA model systems. Results: BZ4 shows antiproliferative activity on different cancer cells; does not affect noncancerous control cells and alters the aggregation properties of β-amyloid, as ascertained by circular dichroism, fluorescence spectroscopy and scanning electron microscopy analysis. An overall, qualitative picture on the mechanistic aspects related to the biological activities is discussed in light of the dynamic light scattering, UV, circular dichroism and fluorescence data, as well as of the metal ion-binding properties of BZ4.

AB - Aim: Our goal is to evaluate benzodifuran-based scaffolds for biomedical applications. Methodology: We here explored the anticancer and anti-amyloid activities of a novel compound (BZ4) in comparison with other known benzodifuran analogs, previously studied in our group, and we have explored its ability to interact with different DNA model systems. Results: BZ4 shows antiproliferative activity on different cancer cells; does not affect noncancerous control cells and alters the aggregation properties of β-amyloid, as ascertained by circular dichroism, fluorescence spectroscopy and scanning electron microscopy analysis. An overall, qualitative picture on the mechanistic aspects related to the biological activities is discussed in light of the dynamic light scattering, UV, circular dichroism and fluorescence data, as well as of the metal ion-binding properties of BZ4.

KW - anti-amyloid

KW - anticancer

KW - synthesis

UR - http://www.scopus.com/inward/record.url?scp=85063617809&partnerID=8YFLogxK

U2 - 10.4155/fmc-2018-0473

DO - 10.4155/fmc-2018-0473

M3 - Article

VL - 11

SP - 285

EP - 302

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

SN - 1756-8919

IS - 4

ER -